YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
Perhaps a test that can predict the later development of Alzheimer's disease: The antyibody is also ised to detect cancer and rheumatoid arthritis Rss feed pubmed
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment